Bd expands fully automated high-throughput molecular diagnostic platform for core labs

Franklin lakes, n.j., dec. 17, 2021 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced it has expanded the bd cor™ system to include a new mx instrument for high-throughput molecular testing for infectious diseases.
BDX Ratings Summary
BDX Quant Ranking